XML 31 R21.htm IDEA: XBRL DOCUMENT v3.26.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2026
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Instruments
The Company measures and reports certain financial instruments as assets and liabilities at fair value on a recurring basis. The fair value of these instruments was as follows:
As of March 31, 2026
Fair ValueLevel 1Level 2Level 3
Liabilities
Contingent royalty obligation payable to Evolus Founders$30,275 $— $— $30,275 
As of December 31, 2025
Fair ValueLevel 1Level 2Level 3
Liabilities
Contingent royalty obligation payable to Evolus Founders$32,182 $— $— $32,182 
Schedule of Contingent Royalty Obligation
The following table provides a reconciliation of the beginning and ending fair value measurement of the contingent royalty obligation payable, which used significant unobservable inputs (Level 3):
Three Months Ended
March 31,
20262025
Fair value, beginning of period$32,182 $44,765 
Payments(1,893)(2,365)
Change in fair value recorded in operating expenses(14)2,151 
Fair value, end of period$30,275 $44,551